Bausch Health Announces Updates Related to Norwich XIFAXAN Matters [Yahoo! Finance]
Bausch Health Companies Inc. (BHC)
Last bausch health companies inc. earnings: 2/19 06:59 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
announced certain updates related to its litigation with Norwich Pharmaceuticals, Inc. With respect to the April 11, 2024, decision of the US Court of Appeals for the Federal Circuit, both Bausch Health and Norwich have filed petitions for panel rehearing or rehearing en banc . The Company anticipates a decision on whether a rehearing will be granted within the next three months. The Company has also received notice of a new Paragraph IV certification (the "Notice"), dated May 10, 2024, from Norwich advising that it has submitted to the U.S. Food and Drug Administration (FDA) an amendment to an Abbreviated New Drug Application (ANDA) requesting approval to market a generic version of XIFAXAN ® (rifaximin) 550 mg tablets for the treatment of irritable bowel syndrome with diarrhea in adults. Bausch Health is reviewing the Notice and has 45 days from receipt of the Notice to commence a patent infringement lawsuit against Norwich. Bausch Health understands that such a lawsuit would
Show less
Read more
Impact Snapshot
Event Time:
BHC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BHC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BHC alerts
High impacting Bausch Health Companies Inc. news events
Weekly update
A roundup of the hottest topics
BHC
News
- Bausch Health Announces Third Quarter 2024 ResultsAccesswire
- Skincare Devices - Strategic Business and Industry Analysis Report 2024-2030 - Emergence of Smart and AI-Enabled Skincare Devices Creates New Opportunities for Market Innovation [Yahoo! Finance]Yahoo! Finance
- ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) RecurrenceAccesswire
- Bausch Health Companies Inc. (NYSE: BHC) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
- South Korea Medical Aesthetics Market Report 2024-2029: Growing Role of Medical Tourism, Popularity of Male Aesthetics, Injectables to Influence Future Growth Prospects [Yahoo! Finance]Yahoo! Finance
BHC
Earnings
- 10/30/24 - Miss
BHC
Sec Filings
- 10/31/24 - Form 10-Q
- 10/30/24 - Form 8-K
- 10/1/24 - Form 4
- BHC's page on the SEC website